Сравнение методов
Просматривайте выбранные методы рядом; строки с различиями подсвечены.
| Односторонний слепой полнофакторный эксперимент× | Одностороннее рандомизированное контролируемое исследование× | |
|---|---|---|
| Область | Планирование эксперимента | Планирование эксперимента |
| Семейство | Process / pipeline | Process / pipeline |
| Год появления≠ | Full factorial: 1935 (Fisher); single-blind clinical convention: mid-20th century | 1948 (formalized); single-blind variant established in mid-20th century clinical trial methodology |
| Автор метода≠ | Full factorial framework: R. A. Fisher; single-blind masking practice: clinical trial tradition, standardized by the 20th century | Bradford Hill and colleagues (MRC streptomycin trial, 1948); blinding conventions codified in CONSORT guidelines |
| Тип≠ | Controlled experimental design | Experimental design — blinded randomized trial |
| Основополагающий источник≠ | Montgomery, D. C. (2017). Design and Analysis of Experiments (9th ed.). Wiley. ISBN: 978-1119113478 | Schulz, K. F., Altman, D. G., Moher, D., & CONSORT Group. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. DOI ↗ |
| Другие названия | single-masked full factorial, single-blind complete factorial, SB-FFE, single-blind all-combinations design | single-masked RCT, single-blind RCT, single-blind trial, SB-RCT |
| Связанные≠ | 6 | 5 |
| Сводка≠ | A single-blind full factorial experiment systematically tests every combination of all factor levels while keeping participants unaware of their treatment assignment. This design allows simultaneous estimation of all main effects and all interaction effects between factors, with single-blind masking reducing participant-side biases such as demand characteristics and expectation effects — without requiring investigator blinding. | A single-blind randomized controlled trial (SB-RCT) is a rigorous experimental design in which participants are randomly assigned to treatment or control conditions while remaining unaware of which condition they have received. Investigators, outcome assessors, and data analysts are not blinded. By masking participants, the design eliminates placebo and nocebo response biases on the participant side, while preserving investigator flexibility to administer and monitor the intervention. |
| ScholarGateНабор данных ↗ |
|
|